{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:41:29Z","timestamp":1793922089110,"version":"4.8.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.urology.2020.01.029","type":"journal-article","created":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T03:39:07Z","timestamp":1580787547000},"page":"8-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Marijuana, Lower Urinary Tract Symptoms, and Pain in the Urologic Patient"],"prefix":"10.1016","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6857-6266","authenticated-orcid":false,"given":"Minh N.","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5961-0020","authenticated-orcid":false,"given":"Matthew T.","family":"Hudnall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Nadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2020.01.029_bib0001","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/andr.12585","article-title":"The relationship between cannabis and male infertility, sexual health, and neoplasm: a systematic review","volume":"7","author":"Rajanahally","year":"2019","journal-title":"Andrology"},{"key":"10.1016\/j.urology.2020.01.029_bib0002","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.juro.2014.04.008","article-title":"Inhibition of peripheral FAAH depresses activities of bladder mechanosensitive nerve fibers of the rat","volume":"192","author":"Aizawa","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2020.01.029_bib0003","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1744-8069-7-31","article-title":"Local activation of cannabinoid CB1 receptors in the urinary bladder reduces the inflammation-induced sensitization of bladder afferents","volume":"7","author":"Walczak","year":"2011","journal-title":"Mol Pain"},{"key":"10.1016\/j.urology.2020.01.029_bib0004","doi-asserted-by":"crossref","first-page":"7147","DOI":"10.1523\/JNEUROSCI.22-16-07147.2002","article-title":"Contrasting effects of WIN 55212-2 on motility of the rat bladder and uterus","volume":"22","author":"Dmitrieva","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.urology.2020.01.029_bib0005","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.eururo.2010.02.027","article-title":"Effects of cannabinor, a novel selective cannabinoid 2 receptor agonist, on bladder function in normal rats","volume":"57","author":"Gratzke","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2020.01.029_bib0006","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.urology.2007.02.069","article-title":"Effects of IP-751, ajulemicacid, on bladder overactivity induced by bladder irritation in rats","volume":"70","author":"Hiragata","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.urology.2020.01.029_bib0007","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.urology.2018.06.054","article-title":"The associationbetween tetrahydrocannabinol and lower urinary tract symptoms utilizing the national health and nutrition examination survey","volume":"123","author":"Fantus","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.urology.2020.01.029_bib0008","doi-asserted-by":"crossref","first-page":"223.e9","DOI":"10.1016\/j.urology.2017.08.011","article-title":"Impact of regular cannabisuse on biomarkers of lower urinary tract function","volume":"109","author":"Nedumaran","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.urology.2020.01.029_bib0009","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1191\/0269215503cr581oa","article-title":"A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms","volume":"17","author":"Wade","year":"2003","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.urology.2020.01.029_bib0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1191\/1352458504ms1063oa","article-title":"An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis","volume":"10","author":"Brady","year":"2004","journal-title":"Mult Scler"},{"key":"10.1016\/j.urology.2020.01.029_bib0011","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s00192-006-0086-x","article-title":"The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS)","volume":"17","author":"Freeman","year":"2006","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1016\/j.urology.2020.01.029_bib0012","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10072-017-3148-6","article-title":"THC\/CBD oromucosal spray in patients with multiple sclerosis overactive bladder: a pilot prospective study","volume":"39","author":"Maniscalco","year":"2018","journal-title":"Neurol Sci"},{"key":"10.1016\/j.urology.2020.01.029_bib0013","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1177\/1352458510378020","article-title":"Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis","volume":"16","author":"Kavia","year":"2010","journal-title":"Mult Scler"},{"key":"10.1016\/j.urology.2020.01.029_bib0014","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jpain.2007.10.018","article-title":"Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy","volume":"9","author":"Narang","year":"2008","journal-title":"J Pain"},{"key":"10.1016\/j.urology.2020.01.029_bib0015","doi-asserted-by":"crossref","first-page":"1514.e15","DOI":"10.1016\/j.urology.2009.12.051","article-title":"Increased cannabinoid receptor 1-immunoreactive nerve fibers in overactive and painful bladder disorders and their correlation with symptoms","volume":"75","author":"Mukerji","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.urology.2020.01.029_bib0016","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejphar.2014.02.013","article-title":"Evaluation of selective cannabinoid CB1 and CB2 receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis","volume":"729","author":"Tambaro","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.urology.2020.01.029_bib0017","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1526-4637.2006.00085.x","article-title":"Experience with the synthetic cannabinoid nabilone in chronic noncancer pain","volume":"7","author":"Berlach","year":"2006","journal-title":"Pain Med"},{"key":"10.1016\/j.urology.2020.01.029_bib0018","doi-asserted-by":"crossref","first-page":"E901","DOI":"10.5489\/cuaj.2268","article-title":"A survey of cannabis (marijuana) use and self-reported benefit in men with chronic prostatitis\/chronic pelvic pain syndrome","volume":"8","author":"Tripp","year":"2014","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.urology.2020.01.029_bib0019","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.urology.2017.02.029","article-title":"Fatty acid amide hydrolase inhibitor treatment in men with chronic prostatitis\/chronic pelvic pain syndrome: an adaptive double-blind, randomized controlled trial","volume":"103","author":"Wagenlehner","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.urology.2020.01.029_bib0020","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: a systematic review and meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2020.01.029_bib0021","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jpain.2015.07.009","article-title":"Inhaled cannabis forchronic neuropathic pain: a meta-analysis of individual patient data","volume":"16","author":"Andreae","year":"2015","journal-title":"J Pain"},{"key":"10.1016\/j.urology.2020.01.029_bib0022","article-title":"Cannabis\u2010based medicines for chronic neuropathic pain in adults","author":"M\u00fccke","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.urology.2020.01.029_bib0023","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/AAP.0000000000000654","article-title":"Perioperative patient beliefs regarding potential effectiveness of marijuana (Cannabinoids) for treatment of pain: a prospective population survey","volume":"42","author":"Khelemsky","year":"2017","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.urology.2020.01.029_bib0024","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1177\/0269881117699616","article-title":"Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep","volume":"31","author":"Piper","year":"2017","journal-title":"JPsychopharmacol (Oxford)"},{"key":"10.1016\/j.urology.2020.01.029_bib0025","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0304-3959(03)00331-2","article-title":"Lack of analgesic efficacy of oral delta-9-tetrahydrocannabinol in postoperative pain","volume":"106","author":"Buggy","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.urology.2020.01.029_bib0026","article-title":"Weeding out the problem: the impact of preoperative cannabinoid use on pain in the perioperative period","author":"Liu","year":"2018","journal-title":"Anesth Analg"},{"key":"10.1016\/j.urology.2020.01.029_bib0027","doi-asserted-by":"crossref","first-page":"18-002","DOI":"10.7812\/TPP\/18-002","article-title":"Marijuana's influence on pain scores, initial weight loss, and other bariatric surgical outcomes","volume":"22","author":"Bauer","year":"2018","journal-title":"Perm J"},{"key":"10.1016\/j.urology.2020.01.029_bib0028","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s12630-017-0814-3","article-title":"A randomized-controlled trial of nabilone for the prevention of acute postoperative nausea and vomiting in elective surgery","volume":"64","author":"Levin","year":"2017","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.urology.2020.01.029_bib0029","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.amjsurg.2018.10.053","article-title":"Impact of recreational and medicinal marijuana on surgical patients: a review","volume":"217","author":"Bakshi","year":"2019","journal-title":"Am J Surg"},{"key":"10.1016\/j.urology.2020.01.029_bib0030","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/1440-1681.12355","article-title":"Elevated cannabinoid receptor 1 and G protein-coupled receptor 55 expression in proximal tubule cells and whole kidney exposed to diabetic conditions","volume":"42","author":"Jenkin","year":"2015","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.urology.2020.01.029_bib0031","doi-asserted-by":"crossref","first-page":"E5420","DOI":"10.1073\/pnas.1419901111","article-title":"Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy","volume":"111","author":"Jourdan","year":"2014","journal-title":"ProcNatl Acad Sci USA"},{"key":"10.1016\/j.urology.2020.01.029_bib0032","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0306-4522(01)00496-1","article-title":"Vanilloid receptor 1 expression in the rat urinary tract","volume":"109","author":"Avelino","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.urology.2020.01.029_bib0033","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/22761","article-title":"Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide","volume":"400","author":"Zygmunt","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.urology.2020.01.029_bib0034","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.bjp.0703050","article-title":"The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)","volume":"129","author":"Smart","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.urology.2020.01.029_bib0035","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.2016.68.5206","article-title":"Management of chronic pain in survivors of adult cancers: american society of clinical oncology clinical practice guideline","volume":"34","author":"Paice","year":"2016","journal-title":"JCO"},{"issue":"suppl 4","key":"10.1016\/j.urology.2020.01.029_bib0036","doi-asserted-by":"crossref","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","article-title":"Management of cancer pain in adult patients: ESMO clinical practice guidelines","volume":"29","author":"Fallon","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.urology.2020.01.029_bib0037","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jpainsymman.2009.06.008","article-title":"Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain","volume":"39","author":"Johnson","year":"2010","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.urology.2020.01.029_bib0038","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jpain.2012.01.003","article-title":"Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial","volume":"13","author":"Portenoy","year":"2012","journal-title":"J Pain"},{"key":"10.1016\/j.urology.2020.01.029_bib0039","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/2049463717710042","article-title":"Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies","volume":"11","author":"Fallon","year":"2017","journal-title":"Br J Pain"},{"key":"10.1016\/j.urology.2020.01.029_bib0040","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jpainsymman.2017.09.001","article-title":"Results of a double-blind, randomized, placebo-controlled study of nabiximols oromucosal spray as an adjunctive therapy in advanced cancer patients with chronic uncontrolled pain","volume":"55","author":"Lichtman","year":"2018","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.urology.2020.01.029_bib0041","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejim.2018.01.023","article-title":"Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer","volume":"49","author":"Bar-Lev Schleider","year":"2018","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.urology.2020.01.029_bib0042","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/2049463717710042","article-title":"Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies","volume":"11","author":"Fallon","year":"2017","journal-title":"Br J Pain"},{"key":"10.1016\/j.urology.2020.01.029_bib0043","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10072-017-3148-6","article-title":"THC\/CBD oromucosal spray in patients with multiple sclerosis overactive bladder: a pilot prospective study","volume":"39","author":"Maniscalco","year":"2018","journal-title":"Neurol Sci"},{"key":"10.1016\/j.urology.2020.01.029_bib0044","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jama.1979.03300040037022","article-title":"Urinary retention following cannabis ingestion","volume":"242","author":"Burton","year":"1979","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2020.01.029_bib0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1526-4637.2006.00085.x","article-title":"Experience with the synthetic cannabinoid nabilone in chronic noncancer pain","volume":"7","author":"Berlach","year":"2006","journal-title":"Pain Med"},{"key":"10.1016\/j.urology.2020.01.029_bib0046","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/JU.0000000000000248","article-title":"Cannabis and male fertility: a systematic review","volume":"202","author":"Payne","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2020.01.029_bib0047","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1186\/s12885-015-1905-6","article-title":"Cannabis exposureand risk of testicular cancer: a systematic review and meta-analysis","volume":"15","author":"Gurney","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.urology.2020.01.029_bib0048","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/ijir.2008.43","article-title":"Early endothelial dysfunction as a marker of vasculogenic erectile dysfunction in young habitual cannabis users","volume":"20","author":"Aversa","year":"2008","journal-title":"Int J Impot Res"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429520301138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429520301138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T02:05:50Z","timestamp":1758765950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429520301138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":48,"alternative-id":["S0090429520301138"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2020.01.029","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Marijuana, Lower Urinary Tract Symptoms, and Pain in the Urologic Patient","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2020.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}